Melilot (Melilotus officinalis)

Melilot (Melilotus officinalis) contains coumarins, particularly melilotoside and coumarin, which provide anticoagulant and anti-inflammatory effects. The herb demonstrates antioxidant activity through compounds like caffeic acid, luteolin, and quercetin with IC50 values under 10 μg/mL.

Origin & History

Melilotus officinalis, commonly known as yellow sweet clover or melilot, is a legume plant native to Europe and western Asia that has been traditionally used in herbal medicine. The herb is typically extracted using ethanol or aqueous methods from the aerial parts (leaves, stems, and flowers), yielding a complex mixture of bioactive compounds including coumarins, flavonoids, and phenolic acids.

Historical & Cultural Context

Melilot has been traditionally used in European and western Asian herbal medicine, though specific historical applications and duration of use are not detailed in the available research. The plant has been recognized in traditional medicine systems, but comprehensive ethnobotanical documentation is lacking in the provided sources.

Health Benefits

• Antioxidant properties: Compounds isolated from melilot, particularly caffeic acid, luteolin, and quercetin, demonstrated superior free radical scavenging capacity with IC50 values <10 μg/mL (in vitro evidence only)
• Anti-inflammatory effects: Inhibited release of nitric oxide, TNF-α, and IL-6 in LPS-stimulated macrophage cells, with one historical reference noting effects comparable to hydrocortisone (primarily in vitro evidence)
• Potential antitumor activity: Compounds 1 and 2 exhibited activity against MCF-7 breast cancer cells with IC50 values of 4.83 and 5.18 μg/mL respectively (in vitro evidence only)
• Immune modulation: Historical reference notes reduced circulating phagocyte activation and lowered citrulline production (limited clinical evidence)
• Cellular protection: Multiple phenolic compounds demonstrated protective effects against oxidative stress markers (in vitro evidence only)

How It Works

Melilot's bioactive coumarins, including melilotoside and coumarin, inhibit vitamin K-dependent clotting factors and reduce platelet aggregation. Flavonoid compounds like luteolin and quercetin scavenge free radicals and inhibit inflammatory mediators including TNF-α, IL-6, and nitric oxide release. The herb's saponins may contribute to vascular permeability reduction and lymphatic drainage enhancement.

Scientific Research

The available research primarily consists of phytochemical analysis and in vitro cellular studies rather than human clinical trials. One historical reference mentions a 2002 study showing anti-inflammatory effects comparable to hydrocortisone, but no PubMed PMIDs or detailed trial parameters are provided in the available sources. Clinical evidence for human use is notably absent from the current research dossier.

Clinical Summary

Most evidence for melilot comes from in vitro studies demonstrating antioxidant activity with IC50 values <10 μg/mL for free radical scavenging. Limited human studies have examined melilot in combination formulas for chronic venous insufficiency, showing modest improvements in leg swelling and discomfort. Traditional use focuses on wound healing and varicose veins, but controlled clinical trials are lacking. The evidence base remains preliminary and requires larger, well-designed human studies.

Nutritional Profile

Melilot (Melilotus officinalis) is a herb used primarily for its bioactive phytochemical content rather than macronutrient density. Macronutrient data for isolated culinary/medicinal use is limited, but as a leguminous herb, dried aerial parts contain approximately 15-20% crude protein, 3-5% crude fat, and 30-40% carbohydrates including structural polysaccharides. Crude fiber content is estimated at 20-25% in dried plant material. Key bioactive compounds include: coumarin (0.4-0.9% dry weight in flowering tops), the primary characteristic compound; melilotoside (coumarin glucoside precursor); o-coumaric acid glycosides; dicoumarol (formed via fungal fermentation of coumarin, NOT present in fresh plant under normal conditions); flavonoids including quercetin, luteolin, and kaempferol (combined estimated 0.5-1.2% dry weight); caffeic acid and other hydroxycinnamic acid derivatives (~0.3-0.8% dry weight); coumestrol (a phytoestrogen); and saponins (~2-4% dry weight). Volatile essential oils include α-pinene, β-pinene, and eugenol in trace amounts. Mineral content includes calcium (~1,200-1,800 mg/100g dried), potassium (~1,500-2,000 mg/100g dried), magnesium (~200-350 mg/100g dried), and iron (~20-35 mg/100g dried), consistent with leguminous aerial plant material. Vitamin K activity is present but not precisely quantified in isolated herb preparations. Bioavailability note: coumarin is rapidly absorbed orally and undergoes first-pass hepatic metabolism to 7-hydroxycoumarin; flavonoid bioavailability is moderate (~10-30%) and enhanced by co-consumption with dietary fats; saponin content may mildly reduce absorption of co-ingested minerals. Protein quality is incomplete (limiting amino acids not fully characterized for this species).

Preparation & Dosage

No clinically studied dosage ranges are available in the provided research for melilot extract, powder, or standardized preparations. Without human clinical trial data, standardized dosage recommendations cannot be established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Luteolin, Green Tea Extract, Turmeric, Resveratrol

Safety & Interactions

Melilot contains coumarins that may enhance anticoagulant medications like warfarin, potentially increasing bleeding risk. Common side effects include headache, nausea, and skin sensitivity with prolonged use. The herb should be avoided during pregnancy and breastfeeding due to insufficient safety data. Individuals with liver disease should exercise caution as coumarins require hepatic metabolism.